Cellectis bioresearch Establishes The Genome Customization Award (TGCA)

Printer-friendly versionPDF version

Cellectis bioresearch, the specialist in genome customization and a subsidiary of Cellectis (Alternext: ALCLS), announced today the first edition of The Genome Customization Award, for academic research teams across the world who are undertaking targeted modification of the genome of a cell line or that of a model organism using one or more meganucleases provided by Cellectis bioresearch.

16 Jun 2010

Paris, June 16, 2010 - Cellectis bioresearch, the specialist in genome customization and a subsidiary of Cellectis (Alternext: ALCLS), announced today the first edition of The Genome Customization Award, for academic research teams across the world who are undertaking targeted modification of the genome of a cell line or that of a model organism using one or more meganucleases provided by Cellectis bioresearch.

“Through this award, Cellectis bioresearch aims at spreading the use of meganucleases for genome customization, throughout the Life Sciences community”, explained Marc Le Bozec, CEO of Cellectis bioresearch. Priority will be given to innovative projects allowing a technological breakthrough.

The winning academic team will receive €15,000 (US$18,000) to partially fund one postdoctoral fellow recruited to work on the project, for one year, with a possible renewal for a second year.

The deadline for submitting applications is October 1, 2010. The winner will be announced on December 15, 2010, by a selection committee composed of respected genetic experts at some of the most well regarded academic institutions inc16 Jun 2010

Paris, June 16, 2010 - Cellectis bioresearch, the specialist in genome customization and a subsidiary of Cellectis (Alternext: ALCLS), announced today the first edition of The Genome Customization Award, for academic research teams across the world who are undertaking targeted modification of the genome of a cell line or that of a model organism using one or more meganucleases provided by Cellectis bioresearch.

“Through this award, Cellectis bioresearch aims at spreading the use of meganucleases for genome customization, throughout the Life Sciences community”, explained Marc Le Bozec, CEO of Cellectis bioresearch. Priority will be given to innovative projects allowing a technological breakthrough.

The winning academic team will receive €15,000 (US$18,000) to partially fund one postdoctoral fellow recruited to work on the project, for one year, with a possible renewal for a second year.

The deadline for submitting applications is October 1, 2010. The winner will be announced on December 15, 2010, by a selection committee composed of respected genetic experts at some of the most well regarded academic institutions including :

* Prof. Rodney J. Rothstein (Columbia University, New York, USA, Committee Chairman)
* Prof. James E. Haber (Brandeis University, Waltham, USA)
* Prof. Alain Fischer (Hôpital Necker – Enfants Malades, Paris, France)

For full program detail or to apply, go to www.cellectis-bioresearch.com/award/.luding :

* Prof. Rodney J. Rothstein (Columbia University, New York, USA, Committee Chairman)
* Prof. James E. Haber (Brandeis University, Waltham, USA)
* Prof. Alain Fischer (Hôpital Necker – Enfants Malades, Paris, France)

For full program detail or to apply, go to www.cellectis-bioresearch.com/award/.

News Source : Cellectis bioresearch Establishes The Genome Customization Award (TGCA)